{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-012552","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.428102+00:00","generated_at":"2026-05-15T23:10:23.482008+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ginkgo Bioworks sells Biosecurity segment to Tower Biosecurity for 20% stake","bullets":["Ginkgo contributes all equity of Ginkgo Biosecurity, LLC (its Biosecurity segment) to Tower Biosecurity.","In exchange, Ginkgo receives shares representing ~20% of Tower Biosecurity on a fully diluted basis.","Transaction expected to close in first half of 2026, subject to customary closing conditions.","Seller is Ginkgo Bioworks, Inc.; parent Ginkgo Bioworks Holdings is party for limited purposes.","No cash purchase price disclosed; consideration is solely an equity stake in the acquirer."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-012552","json":"https://secwatch.observer/filing/0001628280-26-012552.json","markdown":"https://secwatch.observer/filing/0001628280-26-012552.md","text":"https://secwatch.observer/filing/0001628280-26-012552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/0001628280-26-012552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/dna-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:10:23.482008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b28baf85e7921938508139cf3c151308b71e25b8","claim":"Ginkgo Bioworks Holdings, Inc. entered into Stock Purchase Agreement with Tower Biosecurity, Inc. (effective 2026-02-26).","evidence_excerpt":"On February 26, 2026, Ginkgo Bioworks, Inc. (the “Seller”), a wholly owned subsidiary Ginkgo Bioworks Holdings, Inc. (the “Company”), entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Tower Biosecurity, Inc. (the “Purchaser”) and Ginkgo Biosecurity, LLC (“Biosecurity”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/0001628280-26-012552-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Tower Biosecurity, Inc."},{"label":"Effective","value":"2026-02-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}